The ICH E9 guideline provides a comprehensive overview of the statistical principles necessary for designing, conducting, and analyzing clinical trials. It emphasizes the importance of statistical considerations in ensuring that trial data are credible and accurately reflect the efficacy and safety of new cancer treatments.
